Bone biology and anabolic therapies for bone: current status and future prospects.
about
The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.A medium-chain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-κB signaling and blocks cytoskeletal organization and survival in mature osteoclasts.Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs)MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation.Sclerostin inhibition: a novel therapeutic approach in the treatment of osteoporosis.Dynamic interplay between bone and multiple myeloma: emerging roles of the osteoblastSmall molecule inhibitors of the Dishevelled-CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapyProlonged Pharmacokinetic and Pharmacodynamic Actions of a Pegylated Parathyroid Hormone (1-34) Peptide Fragment.NF-κB signaling regulates cell-autonomous regulation of CXCL10 in breast cancer 4T1 cells.Osteoblast dysfunctions in bone diseases: from cellular and molecular mechanisms to therapeutic strategies.Local and targeted drug delivery for bone regeneration.β₂ adrenergic receptor activation suppresses bone morphogenetic protein (BMP)-induced alkaline phosphatase expression in osteoblast-like MC3T3E1 cells.Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.LL-37 peptide enhancement of signal transduction by Toll-like receptor 3 is regulated by pH: identification of a peptide antagonist of LL-37.Regulation of osteogenic differentiation by DNA methylation of the dishevelled gene in bone marrow mesenchymal stem cells.The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density.Differentially Expressed MicroRNAs in Conservatively Treated Nontraumatic Osteonecrosis Compared with Healthy Controls.Optimizing Sequential and Combined Anabolic and Antiresorptive Osteoporosis Therapy
P2860
Q33669039-5AF7C34F-19B7-437F-B647-ECCAA922569CQ34092086-70E9E1D3-613D-40F5-A33D-E4A5611BECC6Q35206754-22D337D4-A85C-4539-B685-B4B7C8B646BEQ35408720-E4CC1929-3992-4645-87C3-E1FF00C86507Q35694436-0D861195-7594-4558-AC07-55DB9543CF07Q36086488-2456990C-CC77-4DA2-AE7E-AF251B802B1FQ36759505-2637986F-300D-445F-A137-C3F35B90739DQ37544925-E05D053F-0E5A-4B8E-8D7C-94B2F430848AQ37680059-999701A9-F1E8-4773-B364-48B8B33B31C3Q38285398-E9313B72-AC7B-47D4-819C-7A73AA5AE9E0Q38804309-5571F727-8F18-4B1A-BB92-C07C09399A11Q38925783-3F141678-9E02-45F0-B299-7DF788768954Q39183207-DFE7C632-D9B7-40B1-A07D-856CD1D3BB3EQ42019549-B5F1DAB1-3DC7-4A0D-9CD7-3E5DF3C9E4C1Q47106962-D94A5A1C-4DB8-4E6F-BFEB-D89BE6201203Q51161134-950F1952-1FFA-4F9D-89AD-5A36318DA468Q53599930-5D7A109E-FF43-474B-ADCE-A6BD3DA4C578Q55420241-24D99F52-F54F-4458-9381-E81CC9C96400Q57147876-7A484E0F-B477-411B-8907-6B730FAE961A
P2860
Bone biology and anabolic therapies for bone: current status and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bone biology and anabolic therapies for bone: current status and future prospects.
@en
Bone biology and anabolic therapies for bone: current status and future prospects.
@nl
type
label
Bone biology and anabolic therapies for bone: current status and future prospects.
@en
Bone biology and anabolic therapies for bone: current status and future prospects.
@nl
prefLabel
Bone biology and anabolic therapies for bone: current status and future prospects.
@en
Bone biology and anabolic therapies for bone: current status and future prospects.
@nl
P2860
P356
P1476
Bone biology and anabolic therapies for bone: current status and future prospects.
@en
P2093
T John Martin
P2860
P356
10.11005/JBM.2014.21.1.8
P577
2014-02-28T00:00:00Z